Experience with Platinum–Paclitaxel Chemotherapy in the Initial Management of Papillary Serous Carcinoma of the Peritoneum

Objective.The objective of this study was to assess the activity and toxicity of combination platinum–paclitaxel chemotherapy in the initial management of patients with papillary serous carcinoma of the peritoneum (PSCP). Methods.Patients initially treated at The Cleveland Clinic Foundation (CCF) fo...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Gynecologic oncology 1998-11, Vol.71 (2), p.288-290
Hauptverfasser:	Kennedy, Alexander W., Markman, Maurie, Webster, Kenneth D., Kulp, Barbara, Peterson, Gert, Rybicki, Lisa A., Belinson, Jerome L.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Antineoplastic agents Antineoplastic Combined Chemotherapy Protocols - adverse effects Antineoplastic Combined Chemotherapy Protocols - therapeutic use Biological and medical sciences CA-125 Antigen - blood Carboplatin - administration & dosage Chemotherapy Cisplatin - administration & dosage Cystadenocarcinoma, Papillary - drug therapy Cystadenocarcinoma, Papillary - mortality Humans Medical sciences Middle Aged Paclitaxel - administration & dosage Peritoneal Neoplasms - drug therapy Peritoneal Neoplasms - mortality Pharmacology. Drug treatments
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!